Frederick's Vaccinogen Makes National Business News

Big news for Vaccinogen, a Frederick-based cancer immunotherapy development company leading the way in cancer research. They have just announced the completion of an initial $80 million in financing and have appointed Dr. Benjamin S. Carson, noted pediatric neurosurgeon to Chairman of the Board.

Check out today's article in the Wall Street Journal here.